US Nasdaq stock alert

USA

CLOSING UPDATE: Amgen increases further 0.3%, led NASDAQ Biotechnology higher 12 January 2018 17:58 EST

NEWS BITES - NORTH AMERICA

This is an end of day Alert, produced after today's NASDAQ market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Amgen, NASDAQ's largest medical/biomedical company by market capitalisation, has increased 1.7% to trade at $US185.04 vs. the NASDAQ Biotechnology which strengthened 23.1 points (or 0.7%) to 3,522.9. Representing a weighting of about 13.5% of the index, the stock accounted for 34.5% of today's gain. Compared with the NASDAQ-100 Index which rose 50.0 points (or 0.8%) in the day, this represented a relative price increase of 0.9%.

Technical indicators complementing today's significant uptrend:

+ The positive 2.13 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The 2.5% discount to 12-month high of $US189.80 against the 23.9% premium to 12-month low of $US149.36 suggests the stock continues to push for new highs.

+ The price lifted 2.4% in the last week and climbed 5.0% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Price/Earnings of 18.1 [30.0]

+ Dividend yield of 2.5% [0.9%]

+ Return on Equity 25.8% [17.3%]

+ Return on Assets 9.9% [9.0%]

Other Bullish Signals include:

+ The company is cash rich with Cash to Market Capitalisation at 25.9%.

+ Tobin's Q Ratio is 1.7. Compared with the rest of the market the stock is undervalued.

+ Net profit margin has averaged 30.4% in the last 3 years. This is considered superior and suggests a high margin of safety.

+ As per the Du Pont analysis, Return on Equity is high at 25.8%. Also, this has improved from 24.7% last year.

Note

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

Return on Capital Employed 13.8% [15.4%]

TODAY'S ALERT

Afternoon Alert: Amgen increases 1.4%, leads NASDAQ Biotechnology higher

12 January 2018 13:23 EST

Amgen Inc. (NASDAQ:AMGN) has increased 1.4% to trade at $US184.42 vs. the NASDAQ Biotechnology which strengthened 24.5 points (or 0.7%) to 3,524.3. Representing a weighting of about 13.4% of the index, the stock accounted for 25.9% of today's gain. Trading volume was 1.1 times average so far today.

RECENT ALERT

Afternoon Alert: Amgen decreases 0.8%, leads NASDAQ Biotechnology lower

11 January 2018 13:23 EST

Amgen Inc. (NASDAQ:AMGN) has decreased 0.8% to trade at $US181.33 vs. the NASDAQ Biotechnology which weakened 15.9 points (or 0.5%) to 3,473.6. Representing a weighting of about 13.3% of the index, the stock accounted for 24.2% of today's loss. Trading volume was 87% of average so far today.

Amgen Inc. (O:AMGN)

ISIN: US0311621009

PermID: 4295905537

CIK: 318154

CUSIP: 031162100

Source: www.BuySellSignals.com